Poor Response to Long-term Albendazole Therapy of Hydatid Liver Cysts
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 21 (3) , 323-325
- https://doi.org/10.3109/00365548909035703
Abstract
Seven patients with uncomplicated hepatic hydatid cysts (Echinococcus granulosus) were treated with albendazole 10 mg/kg/day for 2–6 months (mean 4 months). Serial sonographic evaluation showed reduction in cyst size in only 1 patient (the anteroposterior diameter decreased from 16.5 cm to 4.9 cm). Therapy in this patient was discontinued after 4 months due to development of jaundice. Albendazole appears to have a limited role in the treatment of hydatid disease of the liver.This publication has 5 references indexed in Scilit:
- Penetration of albendazole sulphoxide into hydatid cysts.Gut, 1987
- MULTICENTER CLINICAL-TRIALS OF BENZIMIDAZOLECARBAMATES IN HUMAN ECHINOCOCCOSIS1986
- Albendazole—Objective Evidence of Response in Human Hydatid DiseasePublished by American Medical Association (AMA) ,1985
- Albendazole--objective evidence of response in human hydatid diseaseJAMA, 1985
- Abdominal hydatid disease: Computed tomographic and ultrasound changes during albendazole therapyClinical Radiology, 1983